Publications by authors named "Renee Fortner"

Claim this Profile
C
Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.
Thu Thi Pham, Katharina Nimptsch, Krasimira Aleksandrova, Mazda Jenab, Veronika Fedirko, Renée Turzanski Fortner

Int J Cancer· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective investigation of early-onset colorectal cancer risk factors-pooled analysis of three large-scale European cohorts.
Ruhina S Laskar, Neil Murphy, Pietro Ferrari, Paul Brennan, Amanda J Cross, Renée Turzanski Fortner

Br J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of circulating plasma thyroid hormones concentrations and breast cancer risk in the EPIC cohort.
Mathilde His, Agnès Fournier, Thérèse Truong, Amandine Gelot, Anne-Sophie Navionis, Renée T Fortner

EBioMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.
Daniel R Barnes, Jonathan P Tyrer, Joe Dennis, Goska Leslie, Manjeet K Bolla, Renée T Fortner

NPJ Genom Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for Validating Omics Prediction Models: Insights from a Lung Cancer RNA Biomarker Study.
Luca Pestarino, Renée Turzanski Fortner, Therese H Nøst, Ioannis Fotopoulos, Ilona Urbarova

Cancer Epidemiol Biomarkers Prev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.
Nathalie C Støer, Siri Vangen, Deependra Singh, Renée T Fortner, Solveig Hofvind

Br J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Dale Garsed, Tibor Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Renée Fortner

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond deficiency: Clinical and molecular predictors of survival in patients with -deficient tubo-ovarian high-grade serous carcinoma.
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa W Jayawardana, Renée T Fortner

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Education level and risk of breast cancer by tumor subtype in the EPIC cohort.
Margherita Pizzato, Valerie McCormack, Laure Dossus, Umaima Al-Alem, Cyrille Delpierre, Renée Turzanski Fortner

Int J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer.
Victoria Cooley, Renée Turzanski Fortner, Trasias Mukama, Sabine Naudin, Valeria Pala

Int J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-blockers and epithelial ovarian cancer survival: A Norwegian population-based cohort study.
Leif Lukas Löfling, Nathalie C Støer, Erica K Sloan, Sara Nafisi, Renée Turzanski Fortner

Int J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-steroidal anti-inflammatory medication use and endometrial cancer survival: A population-based Norwegian cohort study.
Ala Jabri Haug, Nathalie Støer, Hilde Langseth, Franziska Siafarikas, Edoardo Botteri, Renée Turzanski Fortner

Int J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.
Zhuxuan Fu, Lauren Borho, Sarah E Taylor, Linda E Kelemen, Anna DeFazio, Renée T Fortner

Gynecol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic profile of biodiverse diets in a healthy European cohort.
Bernadette Chimera, Emine Koc Cakmak, Jessica Blanco-Lopez, Jeroen Berden, Carine Biessy, Renée T Fortner

Am J Clin Nutr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.
Charlotte Le Cornet, Audrey Y Jung, Sabine Behrens, Pooja Middha, Thérèse Truong, Renée T Fortner

JAMA Netw Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer - Baseline Findings for CA125.
Rudolf Kaaks, Victoria Cooley, Trasias Mukama, Lauren R Teras, Alpa V Patel, Renée Turzanski Fortner

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway.
Cassia B Trewin-Nybråten, Sigrid Leithe, Torbjørn Paulsen, Hilde Langseth, Renée Turzanski Fortner

Br J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk?
Komodo Matta, Vivian Viallon, Anastasia Chrysovalantou Chatziioannou, Nivonirina Robinot, Roland Wedekind, Renée Turzanski Fortner

Cancer Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins and the risk of gynecological cancer: a Norwegian population-based cohort study.
Leif Lukas Löfling, Nathalie C Støer, Edoardo Botteri, Renée Turzanski Fortner

Int J Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts.
Kristen D Brantley, Michael E Jones, Rulla M Tamimi, Bernard A Rosner, Peter Kraft, Renée T Fortner

Breast Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes-Related Dietary Patterns and Endometrial Cancer Risk and Survival in the European Prospective Investigation into Cancer and Nutrition Study.
Luisa Torres-Laiton, Leila Luján-Barroso, Núria Nadal-Zaragoza, Carlota Castro-Espin, Paula Jakszyn, Renée T Fortner

Nutrients· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship.
Nikos Papadimitriou, Nabila Kazmi, Konstantinos K Tsilidis, Rebecca C Richmond, Brigid M Lynch, Renée Turzanski Fortner

Cancer Epidemiol Biomarkers Prev· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.
See Hyun Park, Pierre-Emmanuel Sugier, Yazdan Asgari, Mojgan Karimi, Rudolf Kaaks, Renée Turzanski Fortner

Thyroid· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway.
Nathalie C Støer, Edoardo Botteri, Kristina Lindemann, Hilde Langseth, Renée Turzanski Fortner

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.
Ed M Dicks, Jonthan P Tyrer, Suzana Ezquina, Michelle Jones, John Baierl, Renée Turzanski Fortner

Eur J Hum Genet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis